27 Mar 2017 | 4:22 PM
 

GlaxoSmithKline Pharmaceuticals Ltd. Share Price Live (BSE)
0

BSE Code: 500660 | NSE Symbol: GLAXO
2,725.00
-29.35
(-1.06 %)
27 Mar 2017 | 03:31 PM
Change company
  • Open (Rs)
    2,750.00
  • Prev. close (Rs.)
    2,754.35
  • High (Rs.)
    2,751.90
  • Low (Rs.)
    2,720.00
  • 52W H (Rs.)
    3,850.00
  • 52W L (Rs.)
    2,600.00
  • Volume (Rs.)
    520
  • MCap (Rs in Cr.)
    23,081.57
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
44.49
Operating Margin (%)
17.29
Gross Profit Margin (%)
16.40
Net Profit Margin (%)
13.61
Total Debt/Equity
0.00
Dividend payout Ratio (Net Profit)
135.27
Earning Retention Ratio
-36.21

News

13 Feb 2017 - 12:08:00-Pharma major GlaxoSmithKline Pharmaceuticals Ltd has reported a drop of 32...
27 Oct 2016 - 16:37:00-Drug maker GlaxoSmithKline Pharmaceuticals on Thursday reported a growth of 3...
25 May 2016 - 16:50:00-GlaxoSmithKline Pharmaceuticals a world's leading research based pharmaceutical and healthcare c...
11 Feb 2016 - 15:46:00-GlaxoSmithKline Pharmaceuticals announced that it has posted a 76...

Announcements

11-Feb-2017
GlaxoSmithKline Phar - Announces Q3 results (Standalone) & Limited Review Report (Standalone) for the Quarter ended December
11-Feb-2017
GlaxoSmithKline Phar - Change in Directorate
11-Feb-2017
GlaxoSmithKline Phar - Results Press Release for December 31 2016
19-Jan-2017
GlaxoSmithKline Phar - Q3 results on Feb 11 2017
10-Jan-2017
GlaxoSmithKline Phar - Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations 2015 for Quarter ended De

Religare Research

27 Mar 2017 | 12:13 PM
Agri Fundamental and Technical report
27 Mar 2017 | 11:01 AM
• Gold registered second weekly rise in a row • Oil gyrated as rising US drilling offset OPEC-led cu...
27 Mar 2017 | 09:20 AM
The Indian rupee rose for a fifth week against the dollar, helped by exporters' greenback sales amid...
27 Mar 2017 | 07:00 AM
We reiterate our view that Nifty will further consolidate in the near future. Suggest focusing on tr...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
4,26,413 144.86 152.22 0.29
4,26,413 144.86 609.79 0.29
4,26,413 144.86 633.15 0.29
4,26,413 144.86 214.74 0.29
4,50,000 101.80 55.68 0.75

Shareholding Pattern

       
Promotors75.00%
Mutual Funds/UTI1.78%
FI/Banks8.34%
Insurance8.34%
FII1.89%
Government0.00%
Others0.99%

Peer Group

Company Intraday Graph
 Sanofi India Ltd.
4,696.05(0.97)
3325
 Dr. Reddy`s Laboratories Ltd.
2,644.00(0.79)
3294
 Alkem Laboratories Ltd.
2,191.00(-0.95)
17141
 Piramal Enterprises Ltd.
1,847.00(-0.64)
3356

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
GlaxoSmithKline Pharmaceuticals Ltd.52.3019.25-72.05
NIFTY(S&P CNX)148.501,136.95322.15
BSE SENSEX420.563,426.34939.16
BSE 500252.211,795.11595.98

Corporate Details

Key Personal
No Data Available
Key Address
Registered Office
Dr. Annie Besant Road,Mumbai,Maharashtra

Tel:022-24959595, Fax:022-24959494

askus@gsk.com
http://www.gsk-india.com
Registrar Office
Karvy Computershare Private Ltd.
Add. :Karvy Selenium Tower B Plot No. 31-32 Gachibowli Financial District Nanakramguda

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for GlaxoSmithKline Pharmaceuticals Ltd. that will help you decide whether to buy, sell or hold GlaxoSmithKline Pharmaceuticals Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against GlaxoSmithKline Pharmaceuticals Ltd.